IL6R and congenital rubella syndrome: Tocilizumab, a monoclonal antibody that blocks signaling through the IL-6 receptor (IL-6R), became a cornerstone of CRS management.564,580–583 In general, patients with grade 1 CRS should be given broad-spectrum antibiotics along with supportive care.